Full Text
Cost-Effectiveness of Vedolizumab for the Management of Moderate-To-Severe Ulcerative Colitis in Thailand

Abstract

Authors

R Sruamsiri

Back to Volume 21, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×